Nano Drugs

To date, various nanodrug systems have been developed for different routes of administration, which include dendrimers, nanocrystals, emulsions, liposomes, solid lipid nanoparticles, micelles, and polymeric nanoparticles. Nanodrug systems have been employed to improve the efficacy, safety, physicochemical properties, and pharmacokinetic/pharmacodynamic profile of pharmaceutical substances. In particular, functionalized nanodrug systems can offer enhanced bioavailability of orally taken drugs, prolonged half-life of injected drugs (by reducing immunogenicity), and targeted delivery to specific tissues. Thus, nanodrug systems might lower the frequency of administration while providing maximized pharmacological effects and minimized systemic side effects, possibly leading to better therapeutic compliance and clinical outcomes. In spite of these attractive pharmacokinetic advantages, recent attention has been drawn to the toxic potential of nanodrugs since they often exhibit in vitro and in vivo cytotoxicity, oxidative stress, inflammation, and genotoxicity. A better understanding of the pharmacokinetic and safety characteristics of nanodrugs and the limitations of each delivery option is necessary for the further development of efficacious nanodrugs with high therapeutic potential and a wide safety margin. Journals are the major source of knowledge for young and aspiring generations who are keen in pursuing their careers in science. This system provides easy access to networks of scientific journals. Authors who contribute their scholarly works to Open Access journals gain remarkable reputation as the research scholars explore these works extensively. This process assures considerable impact factor for the journal and good reputation to the authors that add value to their Academic Performance Index (API) Score. Because of the free access open access journals impact factors are improving.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on September, 2024